NKX3-1 and prostate intraepithelial neoplasia: The next events include the dysregulation of ETS transcription factor, loss of NKX3.1, mutations of SPOP, and TMPRSS2–ERG fusion at the prostatic intraepithelial neoplasia (PIN) stage.